Showing results (3831-3840 of 27,715) with videos related to

Sort By:
Pageof 2,772
Vaccine|November 19, 2008
Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccineThomas A Russo, Janet M Beanan, Ruth Olson, et al.
Vaccine|November 22, 2008
Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunitySyed M Faisal, WeiWei Yan, Sean P McDonough, et al.
Vaccine|November 26, 2008
Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environmentEdith Lederman, Roque Miramontes, John Openshaw, et al.
Vaccine|November 26, 2008
The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient miceMohamed L Salem, C Marcela Diaz-Montero, Sabry A El-Naggar, et al.
Vaccine|November 15, 2008
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccineY Gillet, G C Steri, U Behre, et al.
Vaccine|November 15, 2008
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Vaccine|November 6, 2008
Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic siteMichelle Rémond, Bruno Da Costa, Sabine Riffault, et al.
Vaccine|November 6, 2008
Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patientsMario Cruciani, Carlo Mengoli, Giovanni Serpelloni, et al.
Vaccine|December 2, 2008
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of ageMark Blatter, Leonard R Friedland, Wayde M Weston, et al.
Vaccine|December 2, 2008
Anti-beta-glucan antibodies in healthy human subjectsP Chiani, C Bromuro, A Cassone, et al.
Pageof 2,772